Medical Device Brands: New Products Face Heavy Competition in the US Market

Victoria Cavicchi, pharmaceutical social media researcher
By Victoria Cavicchi,
Research Analyst

It’s no secret that the life sciences commercial landscape is saturated with established brands, and that more products enter the market each year.  Companies must have a strong understanding of their major competitors early in product development as they prepare for launch.  However, medical device brands are very different even from their closest competitors.  As such, companies can expect their products to enter markets with varying degrees of commercial competition.  While some therapeutic areas are more competitive than others, product novelty is also a determining factor as new product planning and commercial executives prepare for launch. Continue reading


Something to Talk About: Gathering the Patient Voice to Inform Customer-Centric Marketing Strategies

Victoria Cavicchi, pharmaceutical social media researcher
By Victoria Cavicchi,
Research Analyst

Today, patients are more involved in their own healthcare decisions than ever before.  While pharmaceutical firms shift their commercial targets to include payer and government systems, marketing and sales teams also benefit by reaching out to their end-users.  Thanks to the abundance of information available on the Internet, as well as a number of health-focused mobile applications, patients are able to more actively engage with doctors and influence treatment plans.  To accommodate these more active consumers, companies should look to patient-centric marketing strategies as an integral part of their commercial mix. Continue reading


Medical Device Development: Looking to External Resources to Drive Product Management

Victoria Cavicchi, pharmaceutical social media researcher
By Victoria Cavicchi,
Research Analyst

Life sciences firms consume a lot of resources — both budgets and time — on medical device development and commercializing their brands.  While many companies prefer to keep development in-house, others look to outside resources to supplement internal capabilities or to bolster their portfolios. For many companies, collaboration or acquisitions are viable options to move medical devices to market. Continue reading


Don’t Call it a Comeback: mHealth Never Went Out of Style

Sarah Ray, regulatory affairs and safety researcher
By Sarah Ray,
Senior Research Analyst

Across the life sciences industry, global not-for-profit partnerships and pharmaceutical manufacturers alike have become increasingly active in the mobile health space.  In 2012, projections indicated that the global smartphone application market would reach up to $718 million. Already, mobile technologies had helped pharmaceutical and device teams facilitate heightened medical awareness and encourage patient adherence.  Continue reading



The Superstars of Digital Healthcare: MM&M Lists ‘Top 40 Healthcare Transformers’

Sarah Ray, regulatory affairs and safety researcher
By Sarah Ray,
Senior Research Analyst

Innovations abound within the pharmaceutical digital marketing space. As a whole, the industry has worked to increase the availability of healthcare information and better address the needs of healthcare consumers. In its recent “Top 40 Healthcare Transformers” article, Medical Marketing and Media provides a snapshot of some of the leading industry innovators.  Many executives have leveraged online platforms to connect with unique industry stakeholders.  Others have modified the way patients receive healthcare by creating new—or rethinking existing— telemedicine platforms.  In some cases, companies have even begun connecting patients with doctors who are prepared to make house calls.  Continue reading


Big Data Storage and Privacy in the Pharmaceutical Industry

Victoria Cavicchi, pharmaceutical social media researcher
By Victoria Cavicchi,
Research Analyst

Within the last few years, Big Data has become one of the most recognizable buzzwords in marketing.  Especially as the healthcare industry moves more towards cultivating a strong digital presence, life sciences industries are looking for ways to use these data.  With access to a plethora of information — from electronic medical records (EMRs) to clinical trial results — firms are seeking out new ways to leverage pharmaceutical Big Data. Continue reading



Making the Most of Digital Marketing Budgets to Produce Valuable Initiatives

Sarah Ray, regulatory affairs and safety researcher
By Sarah Ray,
Senior Research Analyst

Attaining and wisely spending online marketing budgets is essential for companies operating in the digital space.  How companies secure their digital marketing budgets and choose to spend them varies across surveyed pharmaceutical and device organizations. Some companies have a formal budgeting process in place for attaining digital marketing funding. Others receive budgets on an ad-hoc basis. Regardless of how these organizations receive their funding, allocating their available resources often marks the difference between companies abilities to develop successful, meaningful digital campaigns versus ones that fall flat after only a few months. Continue reading


The EU and Mobile Health: Increasing Patient Adherence and Healthcare Efficiency While Protecting Consumers

Natalie DeMasi, clinical development and medical affairs researcher
By Natalie DeMasi,
Research Analyst

Mobile health (mHealth) has been touted for its ability to increase mHealth adherence, facilitate remote data analysis and — if all goes according to plan — revolutionize healthcare as we know it.  The US FDA has only recently released a guidance discussing how it will regulate mHealth initiatives while the EU already has a web of legal framework outlining mHealth regulations.  Cutting Edge Information’s recent study on mHealth finds that Top 20 companies rank EMA and in-country regulations each as a 3.9 out of 5 in terms of difficulty to work with.

But don’t worry app developers of Europe – the EU is on it! Continue reading